Lung cancer has a nasty party trick: it shows up late, dressed as something else, and by the time you realize what's happening, your options have narrowed considerably. About 70% of lung cancers get caught at advanced stages, when the five-year survival rate plummets to roughly 10%. Catch it at...
A tumor is not just a ball of bad cells. It is a construction project. From the moment a cancer establishes itself, it starts remodeling the surrounding tissue into a custom-built ecosystem designed for one purpose: keeping the tumor alive and the immune system out. Oncologists call this the tumor...
Cancer cells are sneaky little operators. They've got schemes within schemes, defense systems, supply chains, and now—thanks to some clever scientists in China—we know they've been running a secret protein party that nobody could photograph until now.
Somewhere between your morning coffee and your lunch break today, about 400 people worldwide heard the words "metastatic colorectal cancer." And for a big chunk of those people, their first round of chemotherapy has already stopped working - which is a bit like discovering your car's brakes failed...
A team of researchers led by Yun Wang and colleagues just discovered that FLT3-ITD has been running a secret operation completely separate from its day job as a kinase. Published in Blood, their study reveals that this mutant protein moonlights as a scaffold - essentially a molecular meeting room...
A lab tech in Boston slides a 96-well plate under the microscope, each tiny well containing human leukemia cells lounging next to freshly isolated macrophages - the immune system's hungriest enforcers. In some wells, the macrophages are going full Pac-Man, gobbling up cancer cells left and right....
Let me tell you about a molecular con artist that's been flying under the radar for years.
Thirty trillion. That's roughly how many cells make up your body, and every single one of them knows its place and job. Except, of course, when cancer crashes the party and starts rewriting the rulebook.
Pancreatic cancer has been running circles around modern medicine for decades. With a five-year survival rate stubbornly parked at 13% and checkpoint immunotherapy benefiting fewer than 1% of patients, PDAC (pancreatic ductal adenocarcinoma, for those who like their acronyms painful) has earned its...
For years, there was this awkward silence in photodynamic therapy research - the kind of silence that happens when everyone's pretending not to notice the elephant in the room. The elephant? Tumors are often hypoxic, meaning they're low on oxygen. And the main weapon we had against them - a...
The problem with lumping all Asian Americans into one statistical bucket is that you end up with a survival rate smoothie - technically accurate on average, but completely useless for understanding what's actually happening to real people.
The villain wasn't hiding in the shadows—it was already inside the house, pretending to be furniture.
Breast cancer screening in America has been stuck at the same red light for decades. Every woman over 40, line up, get your annual mammogram, move along - no detours, no express lanes, no consideration for whether you're driving a moped or a semi-truck. Laura Esserman, Olufunmilayo Olopade, and...
Two molecular imaging agents walk into a prostate cancer clinic. One's been running the show for years. The other just showed up with better stats and a longer half-life. Things are about to get interesting.
A middle-aged woman walks into a colonoscopy, and the gastroenterologist spots something weird in her rectum. Sounds like the setup to a bad joke, but for the doctors at Showa University Northern Yokohama Hospital, it was the beginning of a diagnostic head-scratcher that landed in the pages of Gut...
Hey there, Medicare budget line items. Yeah, you - the ones labeled "cancer care spending." We need to talk.
Here's a math problem: 291 patients, split into two groups, one weapon added to the arsenal, and a 55% reduction in the risk of cancer getting worse. If your oncologist handed you those odds on a napkin, you'd probably ask for the check and head straight to the clinic.
You have surgery. The tumor comes out. The margins are clear. The scans look clean. Your oncologist says the reassuring words: "We got it all." But did they? In a meaningful number of cases, microscopic cancer cells remain - too few to see on any scan, lurking in tissue or circulation, waiting to...
Most photosensitizers - those light-activated molecules designed to torch cancer cells - never make it past the front door. They float around the cytoplasm like a security team that can't get into the building they're supposed to protect. P-NO3, the molecule at the center of a new study published...
A pathologist looks at a tissue slide under a microscope, evaluates cell morphology, architecture, staining patterns, and invasion depth, then renders a diagnosis. This process has been the backbone of cancer diagnosis for over a century. It is also subjective, time-consuming, and limited by human...